Switzerland · Investor

Dow Venture Capital

Last cheque observed Oct 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Growth equityQuiet

GrowthChemicalsCircular EconomyEnergy

Cheques on record
0%of best year0cheques in 12 months, 25 on record
Since the last cheque5146days00hrs00min00sec
Median round$12MRounds led0 of 25Sole investor3 roundsExits4 from the portfolioMostly inUnited States, 76%
Pitch Dow Venture Capital

Dow Venture Capital highlights

  1. 01

    25 rounds on record

  2. 02

    Mostly Series C and Series B: 52% of its rounds

  3. 03

    Sole investor in 3 rounds, median $3.9M

  4. 04

    4 exits from the portfolio

What they do

The homepage text does not mention investment activities.From their own website
Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Stages
Growth
Sectors
ChemicalsCircular EconomyEnergy
Based in
New Paltz, Switzerland
Cold pitches
Not stated

The record

Every round we can evidence, newest first25 appearances

  1. 2012

    1 round

  2. Oct
    RainStorSeries C · US · techcrunch.com$12MWith 4 others
  3. 2011

    1 round

  4. Jul
    Primet Precision MaterialsUS · fis.dowjones.comUndisclosedSole investor
  5. 2010

    4 rounds

  6. Jul
    Xtreme PowerSeries C · US · techcrunch.com$30MWith 2 others
  7. Jun
    Clean Filtration TechnologyVenture · US · deals.venturebeat.com$2.0MSole investor
  8. Mar
    RainStorSeries B · US · earthtimes.org$7.5MWith 3 others
  9. Jan
    NuvosunVenture · US · greentechmedia.com$5.9MSole investor
  10. 2009

    2 rounds

  11. Dec
    PfenexSeries A · US · sec.gov$24MWith 1 other
  12. Jan
    Water Health InternationalSeries D · US · reuters.com$10MWith 1 other
  13. 2008

    3 rounds

  14. Oct
    Biolex TherapeuticsSeries D · US · mitsuiventures.com$60MWith 10 others
  15. Aug
    HandyLabSeries D · US$19MWith 4 others
  16. Jun
    nanoMRSeries A · US · nanomr.com$5.5MWith 2 others
  17. 2007

    5 rounds

  18. Oct
    Oxford ImmunotecSeries C · GB · oxfordimmunotec.com$40MWith 5 others
  19. Sept
    GreatPoint EnergySeries C · US · greatpointenergy.com$100MWith 3 others
  20. May
    Biolex TherapeuticsSeries C · US · biolex.com$30MWith 8 others
  21. May
    MBA PolymersSeries E · US · deals.venturebeat.com$20MWith 3 others
  22. Apr
    SuperprotonicSeries B · US$16MWith 6 others
  23. 2006

    4 rounds

  24. Oct
    AvesoSeries B · US · avesodisplays.com$6.3MWith 2 others
  25. Sept
    SiConnectSeries B · GB$5.3MWith 4 others
  26. Aug
    ZBD DisplaysVenture · GB$5.4MWith 5 others
  27. Jul
    inSilicaVenture · US · soccentral.com$18MWith 4 others
  28. 2005

    4 rounds

  29. Dec
    SionexSeries C · US · sionex.com$12MWith 3 others
  30. Oct
    ZBD DisplaysVenture · GB$4.7MWith 5 others
  31. Aug
    Oxford ImmunotecSeries B · GB · accessmylibrary.com$13MWith 2 others
  32. May
    SiConnectSeries A · GB$4.9MWith 4 others
  33. 2004

    1 round

  34. Dec
    CymbetSeries B · US · cymbet.com$17MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

0 of 3 we have independently watched raise

CREATE ACCOUNTClimate ProtectionMaizeCare™ Clarity Polymer

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

RainStorBought by TeradataUndisclosedDec 2014
Oxford ImmunotecListed$64MNov 2013
NuvosunBought by The Dow Chemical CompanyUndisclosedMar 2013
HandyLabBought by Becton Dickinson$275MOct 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Dow Venture Capital. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Dow Venture Capital

What does Dow Venture Capital invest in?

Dow Venture Capital invests most often at Series C and Series B (52% of the rounds on record), in sectors such as Chemicals, Circular Economy and Energy.

How active is Dow Venture Capital?

25 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2012.

How big are Dow Venture Capital's cheques?

The median round it joins is $12M.

Does Dow Venture Capital lead rounds?

Rarely, if at all: none of its 25 investments on record names it as the lead.

Where does Dow Venture Capital invest?

Most of the companies it backs are in the United States (76%) and the United Kingdom (24%).

Is Dow Venture Capital investing now?

No investments in the last 12 months; the latest was in Oct 2012.

Who does Dow Venture Capital invest alongside?

Most often Prelude Trust (6 rounds together), DFJ Esprit (4 rounds together) and Draper Esprit (4 rounds together).

What kind of investor is Dow Venture Capital?

Dow Venture Capital is a growth equity firm based in New Paltz, Switzerland.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it